• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
photo finish line
Biotech

Biotechs forced to learn new patent tricks to protect pipelines

A new era of global competition means strong patents, longer stealth periods and misdirection can be required to ensure drug developers retain an edge
Will Maddox Jul 12, 2026 12:00pm
GSK ESMO

GSK sees phase 3 win for Hansoh-partnered ADC as justifying hype

Jul 10, 2026 8:39am
Illustration for Fierces Chutes  Ladders feature showing a blue city skyline with executives making career moves o

Idorsia locks in new CEO after shakeup—Chutes & Ladders

Jul 10, 2026 8:30am
Closeup of blue eye on black background

Bausch + Lomb gives up on glaucoma eye drop hopeful after fail

Jul 10, 2026 7:31am
fundraise tracker 2026

Fierce Biotech Fundraising Tracker '26: MindRank funds GLP-1

Jul 10, 2026 5:00am
Hand with tweezers editing DNA

ARPA-H awards up to $160M for custom genetic medicines

Jul 10, 2026 4:00am
More News

Roche ends 2 Huntington’s programs, including Ionis ASO

Jul 9, 2026 2:40pm

Illumina taps new commercial, legal chiefs

Jul 9, 2026 1:26pm

Fate’s CAR-T prospect shows early promise in systemic sclerosis

Jul 9, 2026 10:24am

Biotech revenue plans ‘won’t look as sunny’ after Trump tax bill

Jul 9, 2026 9:28am
See more stories
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings